TP53 and type 2 diabetes mellitus: In the same study, authors also demonstrated that the tumor suppressor Trp53 is a direct target of miR-200 and that ablation of Trp53 or of its downstream target Bax was able to prevent miR-200-induced β-cell apoptosis and, consequently, T2D development.